Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 1,805 | 1,296 | 935 | 56,577 | 3,677 |
| Cost of Goods | 267 | 216 | 134 | 151 | 167 |
| Gross Profit | 1,538 | 1,080 | 801 | 56,426 | 3,510 |
| Operating Expenses | 10,561 | 9,875 | 13,936 | 12,310 | 14,614 |
| Operating Income | -8,756 | -8,579 | -13,001 | 44,267 | -10,937 |
| Other Income | 1,227 | 4 | 60 | 72 | 18 |
| Pre-tax Income | -7,529 | -8,575 | -12,941 | 44,339 | -10,919 |
| Income Tax | N/A | N/A | N/A | N/A | 44 |
| Net Income Continuous | -7,529 | -8,575 | -12,941 | 44,339 | -10,963 |
| Net Income | $-7,529 | $-8,575 | $-12,941 | $44,339 | $-10,875 |
| EPS Basic Total Ops | -223.93 | -335.90 | -503.85 | 1,707.49 | -419.87 |
| EPS Basic Continuous Ops | -228.32 | -329.48 | -497.29 | 1,703.85 | -421.28 |
| EPS Diluted Total Ops | -223.93 | -335.90 | -503.85 | 1,707.49 | -419.87 |
| EPS Diluted Continuous Ops | -228.32 | -329.48 | -497.29 | 1,703.85 | -421.28 |
| EBITDA(a) | $-8,741 | $-8,542 | $-12,926 | $-6,073 | $-13,302 |